X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-01-11 | PHAT | Socks David A | Dir | S - Sale | $35.70 | -40,000 | 1,532,945 | -3% | -$1,428,038 | |||||
| M | 2020-01-04 | PHAT | Nabulsi Azmi | COO | S - Sale | $33.61 | -14,500 | 823,700 | -2% | -$487,275 | |||||
| M | 2020-12-16 | PHAT | Socks David A | Dir | S - Sale | $43.42 | -79,658 | 1,572,945 | -5% | -$3,458,896 | |||||
| M | 2020-12-01 | PHAT | Nabulsi Azmi | COO | S - Sale | $44.74 | -14,500 | 838,200 | -2% | -$648,688 | |||||
| M | 2020-11-09 | PHAT | Socks David A | Dir | S - Sale | $41.30 | -30,342 | 1,652,603 | -2% | -$1,253,198 | |||||
2020-11-02 | PHAT | Nabulsi Azmi | COO | S - Sale | $36.83 | -14,500 | 852,700 | -2% | -$534,026 | ||||||
2020-04-01 | PHAT | Ra Capital Management, L.P. | 10% | P - Purchase | $24.86 | +117,600 | 3,825,008 | +3% | +$2,923,642 | ||||||
| M | 2020-03-27 | PHAT | Ra Capital Management, L.P. | 10% | P - Purchase | $24.58 | +60,600 | 3,707,408 | +2% | +$1,489,264 | |||||
| D | 2019-10-29 | PHAT | Edwards Jonathan S. | Dir | P - Purchase | $19.00 | +1,052,631 | 2,067,861 | +104% | +$19,999,989 | |||||
| D | 2019-10-29 | PHAT | Frazier Life Sciences Ix, L.P. | 10% | P - Purchase | $19.00 | +1,052,631 | 7,284,269 | +17% | +$19,999,989 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |